A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naive or previously treated (washed out) patients with benign prostatic obstruction and lower urinary tract symptoms

Trial Profile

A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naive or previously treated (washed out) patients with benign prostatic obstruction and lower urinary tract symptoms

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 May 2017

At a glance

  • Drugs PSD 506 (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top